UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 118

Sortiert nach

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

Blood, 2010-02, Vol.115 (5), p.1098-1105

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of a Transplantation Regimen of Yttrium-90 Ibritumomab Tiuxetan and High-Dose Chemotherapy in Patients With Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2008-01, Vol.26 (1), p.90-95

2008

Link zum Volltext

Verfügbarkeit prüfen

Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Blood, 2022-06, Vol.139 (25), p.3605-3616

2022

Link zum Volltext

Verfügbarkeit prüfen

Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation

Journal of hematology and oncology, 2018-06, Vol.11 (1), p.87-87, Article 87

2018

Link zum Volltext

Verfügbarkeit prüfen

Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma

Biology of blood and marrow transplantation, 2015-12, Vol.21 (12), p.2136-2140

2015

Link zum Volltext

Verfügbarkeit prüfen

Ethnicity and attitudes towards life sustaining technology

Social science & medicine (1982), 1999-06, Vol.48 (12), p.1779-1789

1999

Link zum Volltext

Verfügbarkeit prüfen

Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma

Blood, 2012-06, Vol.119 (26), p.6379-6381

2012

Link zum Volltext

Verfügbarkeit prüfen

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

Journal of clinical oncology, 2017-01, Vol.35 (1), p.24-31

2017

Link zum Volltext

Verfügbarkeit prüfen

Copper 64–labeled daratumumab as a PET/CT imaging tracer for multiple myeloma

Blood, 2018-02, Vol.131 (7), p.741-745

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Leukemia, 2018-07, Vol.32 (7), p.1567-1574

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Leukemia, 2018-07, Vol.32 (7), p.1567-1574

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients

Blood, 2009-06, Vol.113 (25), p.6465-6476

2009

Link zum Volltext

Verfügbarkeit prüfen

Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients

Transplant infectious disease, 2021-02, Vol.23 (1), p.e13453-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor

Hematological oncology, 2017-09, Vol.35 (3), p.281-287

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term remission of Philadelphia chromosome–positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation–etoposide regimen

Blood, 2008-08, Vol.112 (3), p.903-909

2008

Link zum Volltext

Verfügbarkeit prüfen

Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2016-02, Vol.22 (2), p.268-276

2016

Link zum Volltext

Verfügbarkeit prüfen

Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma

Annals of hematology, 2011-07, Vol.90 (7), p.803-808

2011

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control

Leukemia & lymphoma, 2011-08, Vol.52 (8), p.1463-1473

2011

Link zum Volltext

Verfügbarkeit prüfen

110-P

Human immunology, 2012-10, Vol.73, p.119-119

2012

Link zum Volltext

Verfügbarkeit prüfen

Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

Leukemia research, 2012-09, Vol.36 (9), p.1152-1156

2012

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myeloma

Leukemia & lymphoma, 2014-01, Vol.55 (1), p.201-203

2014

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia

Leukemia & lymphoma, 2011-04, Vol.52 (4), p.719-723

2011

Link zum Volltext

Verfügbarkeit prüfen

Ethnicity and Advance Care Directives

The Journal of law, medicine & ethics, 1996, Vol.24 (2), p.108-117

1996

Link zum Volltext

Verfügbarkeit prüfen

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality

Biology of blood and marrow transplantation, 2002-01, Vol.8 (9), p.493-500

2002

Link zum Volltext

Verfügbarkeit prüfen

Brentuximab Vedotin Is Associated with Improved Progression-Free Survival after Allogeneic Transplantation for Hodgkin Lymphoma

Biology of blood and marrow transplantation, 2014-11, Vol.20 (11), p.1864-1868

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(117)
Buchkapitel
(1)

Sprache

Englisch
(118)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(52)
Science & Technology
(52)
Humans
(47)
Hematology
(40)
Middle Aged
(39)
Female
(38)
Male
(38)
Adult
(34)
Transplantation
(30)
Hematology, Oncology And Palliative Medicine
(26)
Aged
(25)
Immunology
(23)
Oncology
(16)
Young Adult
(16)
Hematopoietic Stem Cell Transplantation
(14)
Hematopoietic Stem Cell Transplantation - Methods
(14)
Transplantation, Homologous
(14)
Treatment Outcome
(14)
Transplantation Conditioning - Methods
(13)
Adolescent
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

Phase II Trial of a Transplantation Regimen of Yttrium-90 Ibritumomab Tiuxetan and High-Dose Chemotherapy in Patients With Non-Hodgkin's Lymphoma

Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation

Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma

Ethnicity and attitudes towards life sustaining technology

Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

Copper 64–labeled daratumumab as a PET/CT imaging tracer for multiple myeloma

Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients

Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients

Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor

Long-term remission of Philadelphia chromosome–positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation–etoposide regimen

Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma

Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control

110-P

Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myeloma

Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia

Ethnicity and Advance Care Directives

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality

Brentuximab Vedotin Is Associated with Improved Progression-Free Survival after Allogeneic Transplantation for Hodgkin Lymphoma

Suchergebnisse filtern